No connection

Search Results

BETA

BEARISH
$15.36 Live
BETA Technologies, Inc. · NYSE
Target $36.25 (+136.0%)
$14.18 52W Range $39.5

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 26, 2026
Market cap
$3.66B
P/E
N/A
ROE
-66.2%
Profit margin
N/A
Debt/Equity
0.11
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BETA Technologies exhibits weak financial health per the Piotroski F-Score of 4/9, indicating a fragile operational foundation despite strong revenue growth. The company's profitability metrics are severely impaired, with a negative operating margin of -1210.42% and a negative ROE of -66.19%, signaling deep operational inefficiencies. Although the firm shows robust revenue growth (150.90% YoY) and a high gross margin (72.20%), these are not translating into earnings or cash flow. The absence of a Graham Number and intrinsic value, combined with a forward P/E of -6.24, reflects a market pricing premium based on speculative growth rather than fundamentals. The lack of analyst consensus on target price and neutral insider activity further undermine conviction.

Key Strengths

Exceptional revenue growth of 150.90% YoY, indicating strong market demand or expansion
High gross margin of 72.20% suggests strong pricing power or efficient production
Favorable debt-to-equity ratio of 0.11, indicating low financial leverage
Strong current and quick ratios (22.77 and 22.46) imply excellent short-term liquidity
Analyst consensus of 'strong_buy' reflects optimistic growth expectations

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Negative operating margin (-1210.42%) and ROE (-66.19%) signal severe profitability issues
Forward P/E of -6.24 and lack of earnings data suggest no current profitability
No free cash flow or operating cash flow data available, raising concerns about sustainability
Quarterly earnings surprises are deeply negative (avg -302.61%), indicating poor execution or forecasting

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
28
Weak
Value
25
Future
65
Past
20
Health
30
Dividend
0
AI Verdict
Weak
Key drivers: High revenue growth but catastrophic profitability, Negative operating margins and ROE, Low Piotroski F-Score, No cash flow generation, Speculative valuation
Confidence
88%
Value
25/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Sales of 102.75 is high, but justified by growth expectations
  • Low debt-to-equity ratio supports financial stability
Watchpoints
  • No Graham Number or intrinsic value due to negative earnings
  • Forward P/E is negative, making valuation metrics meaningless
  • Price/Sales is extremely elevated relative to peers
Future
65/100

Ref Growth rates

Positives
  • 150.90% YoY revenue growth is exceptional
  • Analyst target price of $36.25 implies strong growth optimism
  • Recent Q/Q EPS growth of +11.9% suggests improvement in losses
Watchpoints
  • Earnings are still deeply negative
  • No forward earnings guidance or cash flow data
  • Negative earnings surprises indicate execution risk
Past
20/100

Ref Historical trends

Positives
  • Consistent revenue growth over recent quarters
Watchpoints
  • All three quarters missed earnings estimates by large margins
  • Average earnings surprise of -302.61% indicates severe underperformance
  • No history of profitability or positive cash flow
Health
30/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Low debt-to-equity (0.11) and high liquidity (current ratio 22.77)
  • No Altman Z-Score available, but low leverage reduces distress risk
Watchpoints
  • Piotroski F-Score of 4/9 is below threshold for financial health
  • Negative ROE and ROA indicate poor capital efficiency
  • Operating margin is catastrophically negative
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout ratio
  • Dividend strength is 0/100
  • Negative earnings make dividend payment impossible

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$15.36
Analyst Target
$36.25
Upside/Downside
+136.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BETA and closest competitors.

Updated 2026-03-25
BET
BETA Technologies, Inc.
Primary
5Y
-57.3%
3Y
-57.3%
1Y
-57.3%
6M
-57.3%
1M
-15.4%
1W
+3.2%
OTT
Otter Tail Corporation
Peer
5Y
+105.2%
3Y
+26.2%
1Y
+10.6%
6M
+11.2%
1M
-1.3%
1W
-5.2%
AZZ
AZZ Inc.
Peer
5Y
+172.2%
3Y
+204.5%
1Y
+41.4%
6M
+12.9%
1M
+11.0%
1W
+0.2%
SKY
SkyWest, Inc.
Peer
5Y
+78.2%
3Y
+285.3%
1Y
+6.6%
6M
-6.4%
1M
+1.1%
1W
-2.1%
HAY
Hayward Holdings, Inc.
Peer
5Y
-17.8%
3Y
+31.1%
1Y
+20.0%
6M
+2.3%
1M
+19.4%
1W
+3.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-6.24
PEG Ratio
N/A
P/B Ratio
1.94
P/S Ratio
102.75
EV/Revenue
56.79
EV/EBITDA
-5.77
Market Cap
$3.66B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -1210.42%
Gross Margin 72.2%
ROE -66.19%
ROA -16.8%

Growth

Revenue and earnings growth rates

Revenue Growth +150.9%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.11
Low debt
Current Ratio
22.77
Strong
Quick Ratio
22.46
Excellent
Cash/Share
$7.44

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Revenue
$0.0B
Gross Margin
69.3%
Op. Margin
-903.5%
Net Margin
-4902.6%
Total Assets
$1.1B
Liabilities
$0.3B
Equity
$0.8B
Debt/Equity
0.35x
Operating CF
$-0.1B
CapEx
$-0.0B
Free Cash Flow
$-0.1B
FCF Yield
119%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-14
$N/A
2026-03-09
$-1.71
-264.7% surprise
2025-12-04
$-1.94
-340.5% surprise

Industrials Sector Comparison

Comparing BETA against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
Return on Equity (ROE)
-66.19%
This Stock
vs
-19.38%
Sector Avg
+241.5% (Excellent)
Debt to Equity
0.11
This Stock
vs
2.63
Sector Avg
-95.7% (Less Debt)
Revenue Growth
150.9%
This Stock
vs
71.29%
Sector Avg
+111.7% (Fast Growth)
Current Ratio
22.77
This Stock
vs
3.09
Sector Avg
+636.8% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

ABELE JOHN E
Director
Stock Award
2026-01-30
1,071 shares
KAMEN DEAN L. PH.D.
Director
Stock Award
2026-01-30
1,071 shares
DAVIS CHARLES A.
Director
Stock Award
2026-01-30
1,071 shares
ROTHBLATT MARTINE A
Director
Stock Award
2026-01-30
1,071 shares
SLATTERY JOHN S
Director
Stock Award
2026-01-30
1,071 shares
CUETO HERMAN
Chief Financial Officer
Stock Award
2026-01-30
47,321 shares
MCCONVILLE JAMES
Director
Stock Award
2026-01-30
1,071 shares
STONE MICHAEL ROBERT
Director
Stock Award
2026-01-30
1,071 shares
CLARK KYLE
Chief Executive Officer
Stock Award
2026-01-30
208,213 shares
DUNKIEL BRIAN
Officer
Stock Award
2026-01-30
47,321 shares
CHURCHILL DAVID LAWRENCE PH.D.
Chief Technology Officer
Stock Award
2026-01-30
48,285 shares
HUNTER MARK WILLIAM
Officer
Stock Award
2026-01-30
3,785 shares
DONOVAN SEAN
Chief Operating Officer
Stock Award
2026-01-30
47,321 shares
DUNKIEL BRIAN
Officer
Option Exercise
2025-12-31
6,544 shares · $38,098
SLATTERY JOHN S
Director
Stock Award
2025-11-07
203,648 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
8 analysts
Goldman Sachs
2026-03-17
Maintains
Buy Buy
Morgan Stanley
2026-03-10
Maintains
Overweight Overweight
Jefferies
2026-03-10
Maintains
Buy Buy
BTIG
2026-03-10
reit
Buy Buy
Needham
2026-03-09
reit
Buy Buy
Jefferies
2026-02-11
up
Hold Buy
Needham
2026-01-15
reit
Buy Buy
B of A Securities
2025-12-17
Maintains
Buy Buy
Needham
2025-12-05
reit
Buy Buy
Morgan Stanley
2025-12-01
init
Overweight

Past News Coverage

Recent headlines mentioning BETA from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile